These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23996457)

  • 41. Drug therapy for the management of cancer-related fatigue.
    Minton O; Richardson A; Sharpe M; Hotopf M; Stone P
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006704. PubMed ID: 20614448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modafinil for the treatment of methamphetamine dependence.
    Anderson AL; Li SH; Biswas K; McSherry F; Holmes T; Iturriaga E; Kahn R; Chiang N; Beresford T; Campbell J; Haning W; Mawhinney J; McCann M; Rawson R; Stock C; Weis D; Yu E; Elkashef AM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):135-41. PubMed ID: 21840138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment for amphetamine withdrawal.
    Shoptaw SJ; Kao U; Heinzerling K; Ling W
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modafinil for the treatment of cocaine dependence.
    Anderson AL; Reid MS; Li SH; Holmes T; Shemanski L; Slee A; Smith EV; Kahn R; Chiang N; Vocci F; Ciraulo D; Dackis C; Roache JD; Salloum IM; Somoza E; Urschel HC; Elkashef AM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):133-9. PubMed ID: 19560290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychostimulants for cancer-related fatigue.
    Breitbart W; Alici Y
    J Natl Compr Canc Netw; 2010 Aug; 8(8):933-42. PubMed ID: 20870637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder.
    Tanda G; Hersey M; Hempel B; Xi ZX; Newman AH
    Curr Opin Pharmacol; 2021 Feb; 56():13-21. PubMed ID: 32927246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment for amphetamine withdrawal.
    Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
    Cochrane Database Syst Rev; 2001; (4):CD003021. PubMed ID: 11687170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis.
    Miladi N; Dossa R; Dogba MJ; Cléophat-Jolicoeur MIF; Gagnon B
    Support Care Cancer; 2019 Oct; 27(10):3717-3727. PubMed ID: 31250183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modafinil: is it ready for prime time?
    Prommer E
    J Opioid Manag; 2006; 2(3):130-6. PubMed ID: 17319446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modafinil for social phobia and amphetamine dependence.
    Camacho A; Stein MB
    Am J Psychiatry; 2002 Nov; 159(11):1947-8. PubMed ID: 12411237
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
    Mustian KM; Alfano CM; Heckler C; Kleckner AS; Kleckner IR; Leach CR; Mohr D; Palesh OG; Peppone LJ; Piper BF; Scarpato J; Smith T; Sprod LK; Miller SM
    JAMA Oncol; 2017 Jul; 3(7):961-968. PubMed ID: 28253393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WITHDRAWN: Dopamine agonists for cocaine dependence.
    Soares B; Lima Reisser AA; Farrell M; Silva de Lima M
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003352. PubMed ID: 20166066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands.
    Nuijten M; Blanken P; van den Brink W; Hendriks V
    BMC Psychiatry; 2011 Aug; 11():135. PubMed ID: 21854580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials.
    Arkell TR; Bradshaw K; Downey LA; Hayley AC
    Addict Biol; 2022 Mar; 27(2):e13128. PubMed ID: 35229937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapy of methamphetamine addiction: an update.
    Elkashef A; Vocci F; Hanson G; White J; Wickes W; Tiihonen J
    Subst Abus; 2008; 29(3):31-49. PubMed ID: 19042205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment for methaqualone dependence in adults.
    McCarthy G; Myers B; Siegfried N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004146. PubMed ID: 15846700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.